Ligand– tag –
-
Smart Materials and Nanomedicines Play Critical Role in Personalized Cancer Diagnosis and Therapy
AWS (referencing a chapter from a scientific publication) USA Overview Smart materials, particularly nanomedicines, are reported to play a pivotal role in personalized cancer diagnosis and treatment. Targeted nanomedicines, designed to r... -
Insitro Appoints Hideo Makimura as Chief Medical Officer to Accelerate Transition from AI Drug Discovery to Clinical-Stage Company
BioSpace USA Overview Insitro, a pioneer in AI drug discovery, announced the appointment of Hideo Makimura as Chief Medical Officer (CMO), signaling a strategic acceleration from an AI-driven discovery firm to a clinical-stage company. M... -
Ribo Life Science’s siRNA Therapeutic Vortosiran Receives EMA Approval for Stroke Prevention Trial in Atrial Fibrillation Patients
Insight, China's Pharmaceutical Industry China Overview Ribo Life Science's siRNA therapeutic, vortosiran (BD4059), has received European Medicines Agency (EMA) approval for a clinical trial aimed at stroke prevention in atrial fibrillat... -
Tangram Therapeutics Advances TGM-312 to Patient Cohorts in Phase 1/2 RESTORE-MASH Trial for MASH Treatment
BioSpace USA Overview Tangram Therapeutics announced the progression of TGM-312, a novel GalNAc-siRNA therapeutic for MASH (Metabolic Dysfunction-Associated Steatohepatitis), to patient cohorts in its Phase 1/2 RESTORE-MASH trial. TGM-31... -
Silence Therapeutics’ PV Drug Divesiran Achieves 88% Response Rate in Phase 2, Advances to Phase 3
Investing.com UK Overview Silence Therapeutics' GalNAc-siRNA therapeutic, divesiran, for polycythemia vera (PV) met its primary endpoint in the Phase 2 SANRECO study, demonstrating an impressive 88% response rate compared to 19% in the p... -
Machine Learning Force Fields Unravel Carboxylate Ligand Binding on CdSe Quantum Dots at Atomic Level, Paving Way for Enhanced Displays, Solar Cells, and Bioimaging
Scienmag Unknown Overview Groundbreaking research utilizing machine learning force fields has elucidated the atomic-level binding mechanisms of carboxylate ligands on CdSe quantum dots. This discovery clarifies the factors determining na... -
Oligonucleotide Drug Delivery Shifts Beyond Liver-Targeting to Tissue-Specific Approaches for Muscle and CNS
GlobeNewswire Unknown Overview Oligonucleotide drug delivery is evolving significantly, moving from traditional liver-targeted strategies to tissue-specific approaches for extrahepatic organs like muscle and the central nervous system (C... -
Nanotechnology Overcomes Drug Delivery Challenges: Liposomes & Polymeric Nanoparticles Enhance Drug Solubility and Targeted Delivery
Scientific Review Unknown Overview A recent review highlights nanotechnology's transformative role in overcoming traditional drug delivery challenges, such as poor solubility and non-specific distribution. Diverse nanocarriers, including... -
PROTACs vs. Molecular Glues: Comparing Targeted Protein Degraders for Size and Permeability in Drug Selection
Drug Target Review UK Overview PROTACs and molecular glues represent two distinct strategies for targeted protein degradation, each with unique advantages and challenges. PROTACs are bifunctional molecules that recruit an E3 ligase to a ... -
New Blood-Brain Barrier Penetration Strategies: Peptides and ‘Trojan Horse’ Approaches Revolutionize Brain Drug Delivery
Facebook USA Overview The blood-brain barrier (BBB) blocks approximately 95% of drugs, severely impeding treatment for brain disorders. Researchers are developing novel techniques to bypass this barrier, including 'Trojan horse' approach...
